(Q40623595)

22 September 2017

title

Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro (English)

1 reference

22 September 2017

10

1 reference

22 September 2017

Bea Pauwels

1

1 reference

22 September 2017

Annelies E C Korst

2

1 reference

22 September 2017

Greet G O Pattyn

3

1 reference

22 September 2017

Hilde A J Lambrechts

4

1 reference

22 September 2017

Dirk R Van Bockstaele

5

1 reference

22 September 2017

Katrien Vermeulen

6

1 reference

22 September 2017

Marc Lenjou

7

1 reference

22 September 2017

Christel M J de Pooter

8

1 reference

22 September 2017

Jan B Vermorken

9

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

International Journal of Radiation Oncology Biology Physics

22 September 2017

published in

1 reference

22 September 2017

volume

57

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

1075-1083

1 reference

Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Gemcitabine and radiosensitization in human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

The effect of 2'-2' difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Maximizing therapeutic gain with gemcitabine and fractionated radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Radiation enhancement by gemcitabine-mediated cell cycle modulations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

The role of p53 in gemcitabine-mediated cytotoxicity and radiosensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

The radiosensitising effect of gemcitabine and the influence of the rescue agent amifostine in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Optimization of the sulforhodamine B colorimetric assay

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

A Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Mean inactivation dose: a useful concept for intercomparison of human cell survival curves

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Cell cycle effects of gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

Variations in several responses of HeLa cells to x-irradiation during the division cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901443-3

7 January 2021

10.1016/S0360-3016(03)01443-3

Identifiers

DOI

1 reference

22 September 2017

1 reference